Aureus Asset Management’s Celgene Corp CELG Stock Holding History

Aureus Asset Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-6,948	Closed	-$830K	–	194
2017 Q1	$830K	Buy	6,948 +763	+12%	+$91.3K	0.14%	72
2016 Q4	$716K	Sell	6,185 -32	-0.5%	-$3.56K	0.14%	69
2016 Q3	$650K	Buy	6,217 +2,887	+87%	+$312K	0.13%	79
2016 Q2	$328K	Buy	+3,330	New	+$344K	0.07%	84
2016 Q1	–	Sell	-5,698	Closed	-$682K	–	154
2015 Q4	$682K	Buy	5,698 +273	+5%	+$31.6K	0.15%	63
2015 Q3	$587K	Sell	5,425 -240	-4%	-$29.8K	0.15%	72
2015 Q2	$656K	Buy	5,665 +38	+0.7%	+$4.34K	0.14%	80
2015 Q1	$649K	Hold	5,627	–	–	0.15%	77
2014 Q4	$629K	Buy	5,627 +2,377	+73%	+$251K	0.15%	76
2014 Q3	$308K	Hold	3,250	–	–	0.08%	96
2014 Q2	$279K	Sell	3,250 -3,244	-50%	-$247K	0.07%	106
2014 Q1	$453K	Buy	+6,494	New	+$514K	0.12%	99

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Aureus Asset Management's CELG Position: Q2 2017 in Review

Aureus Asset Management sold out of Celgene Corp (CELG) in Q2 2017, closing a stake of 6,948 shares — an estimated $830K sold.

Aureus Asset Management first reported a position in CELG in Q1 2014 and held it in 12 quarters. The position peaked at $830K in Q1 2017. 1,428 funds tracked by Wall St. Rank hold CELG as of Q2 2017.

Aureus Asset Management reported no remaining Celgene Corp position as of Q2 2017 after selling out during the quarter.
Aureus Asset Management sold 6,948 Celgene Corp shares in Q2 2017, an estimated $830K.
Aureus Asset Management first reported a position in Celgene Corp in Q1 2014 and held it in 12 quarters.
Aureus Asset Management's Celgene Corp position peaked at $830K in Q1 2017.
1,428 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2017.

Based on Aureus Asset Management's 13F filing for Q2 2017, filed 14 Aug 2017.